Explore other Johns Hopkins Sites
 
 
 
 
 

Disease Information

Neisseria Meningitidis

Meningococcal Infections: The Ongoing Saga

Chemoprophylaxis for Health Care Workers Exposed to
N. meningitidis

by Trish M. Perl, M.D., M.Sc.  

Rationale:

  • 1.3 to 5.8% “secondary” cases result from exposure to a N. meningitidis case
  • the attack rate in persons exposed to a case with close contact (i.e. household) is 500 to 800 times that of the general population
  • up to 85% of persons with “close” contact carry N. meningitidis in their oropharynx after exposure to a case whereas 5-11% of persons living in crowded conditions carry N. meningitidis in the oropharynx.
  • In general, hospital personnel have the same risk of developing disease as the general population unless they have contact with respiratory secretions.  However, disease in health care workers is rare and thought to be in part due to patient isolation and treatment that decrease the chance of becoming a carrier.

 A prophylactic agent must:

  • be safe
  • eliminate carriage rapidly and for a prolonged period
  • achieve bactericidal concentrations in saliva and tears
  • cost effective
  • limit change of antimicrobial resistance


In the health care setting, an agent also should be

  • practical (to assure compliance) 

Review of the literature: see attached sheet

  • Sulfonamides are no longer used because of wide spread drug resistance.

References:

  1. Pusley, Dworzack, Horowitz et al.. Efficacy of Ciprofloxacin in the treatment of nasopharyngeal carriers of N. Meningitidis JID 1987:211-213.

  2. Pusley, Dworzack, Roccaforte et al.. An Open study of the efficacy of a single dose of Ciprofloxacin in eliminating the chronic nasopharyngeal carriage of N. Meningitidis JID 1988 157:852-3.

  3. Gutter, Beaty.  Minocycline in the chemoprophylaxis of meningococcal disease. AAC 1972397-402

  4. Gaunt, Lambert.  Single dose of Ciprofloxacin for the eradication of pharynceal carriage of N. Meningitidis.  J Antimicrob Chemother 1988 21:489-96.

  5. Judson, Ehret. Single dose ceftriaxone to eradicate pharyngeal N. Meningitidis  Lancet 1984.22/29:1462-3. 

  6. Devine, Johnson, Hagerman etal.  The effect of minocycline on meningococcal nasopharyngeal carrier state in naval personnel.  Am J Epidemiol 1971;93:337-45 

Efficacy

Side Effects

Resistance

Dose

Cost

Comments

Rifampin

75-90%

colored secretions
efficacy of BCP
25%side effects

10%

300 BID
2 days

$11.58

Red book & CDC recommendation contraindicated in pregnancy

Ceftriaxone

97%

pain at injection

none reported

250 mg

$7.76

Use in pregnancy
Ciprofloxacin

93%

none reported

not reported

500 mg

$3.24

> 16 yrs
contraindicated in pregnancy
eradicates 75% of chronic carriers
Minocycline

84%

33% vertigo

67%

200mg load
100 BID X 5d
$68.40
experience in outbreaks

 


 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries